DigiTx Partners

About The Fund

DigiTx Partners is a venture capital firm specializing in early-stage investments, with a focus on transforming the healthcare and life sciences industries through technology and data. Launched in 2016 as a joint venture between Astellas Pharma and MPM Capital, DigiTx is based in South San Francisco, California, and dedicates its efforts to backing companies that work on solving complex challenges and inefficiencies in healthcare. They invest in digital health companies at the inflection point of revolutionizing healthcare and improving patient outcomes with innovative and cutting-edge technology solutions. Their investment range lies between $2,000,000 and $4,000,000, with a sweet spot of around $3,000,000. DigiTx Partners' specialities include Early, Seed, and Series A funding rounds. Their investment thesis revolves around three key areas: Personalized Medicine, Data Analytics, and Digital Therapeutics. They aim to move away from generic treatment methods towards tailored approaches by integrating biometric signals and omics data to refine treatment and prevention. Their emphasis on data analytics focuses on investing in solutions that intelligently analyze healthcare data, generating meaningful insights for improved patient and population outcomes. In the realm of digital therapeutics, they foresee a future where software is routinely prescribed to treat patients with both acute and chronic conditions, with evidence-based and clinically validated digital interventions. DigiTx Partners believes in the power of patient-focused, data-driven technologies that leverage proprietary or public data to generate competitive insights. They maintain a portfolio of companies that reflect their vision of enhancing patient lives and the healthcare ecosystem.